DataJoint, a leading computational database and AI platform designed to streamline data management and accelerate research in neuroscience, oncology, and systems biology, today announced the successful closing of its $4.9 million Seed funding round. The round was co-led by Barcelona-based Nina Capital, Salt Lake City-based Inoca Capital Partners, and Austin-based Capital Factory, with additional participation from existing investors. DataJoint's geographically diverse investor base reflects the international commercial potential of its platform. The company already has customers and partners in multiple countries.

Founded to address inefficiencies in academic and pharmaceutical research labs, DataJoint provides a unified database infrastructure that harmonizes multimodal data sources into automated workflows. The company's SaaS platform is built on an open-source foundation, with plans to achieve SOC2, HIPAA, and ISO27001 compliance to serve a growing customer base in academia and industry.